Active not recruitingOBSERVATIONAL

Impact of Door-to-Needle Time on Stroke Outcomes at Gonesse Hospital

Doctors at Gonesse Hospital are studying how quickly people who have a stroke receive an important clot-dissolving medicine. This medicine is given through a needle. The study wants to find out if giving this medicine faster after a patient arrives at the hospital helps them recover better. They will measure the time it takes from when a patient arrives at the hospital to when they get this treatment. They will also look at the time from when stroke symptoms first started to when the patient got to the hospital. The main goal is to understand if delays in treatment affect how well someone recovers from a stroke, and to find ideas to make stroke care quicker and more effective at their hospital.

At a glance

Status

Active not recruiting

Sponsor

Centre Hospitalier de Gonesse

Enrolment target

Start

01 May 2025

Estimated completion

01 Sep 2025

Stroke Ischemic Attack, Transient Cerebral Infarction Thrombolytic Therapy Treatment Outcome

What is this study about?

When someone has a stroke, it's often caused by a blood clot blocking blood flow to part of the brain. A treatment called 'thrombolysis' uses medication to dissolve these clots, which can help limit damage to the brain. This study at Gonesse Hospital is looking closely at how quickly patients who have had a stroke receive this vital clot-dissolving medication once they arrive at the hospital. This specific time is often called 'Door-to-Needle Time'.

The researchers will collect information from patients who came to Gonesse Hospital because of a stroke. They want to see if shorter 'Door-to-Needle Time' leads to better recovery for these patients. They will also consider how long it took for patients to get to the hospital after their stroke symptoms started. The results of this study could help the hospital understand if their current processes are working well and identify any areas where they could speed things up.

Ultimately, the aim is to find ways to make stroke care more efficient and effective. By understanding the link between how quickly treatment is given and how well patients recover, the hospital hopes to improve its care for future stroke patients, potentially leading to better outcomes for more people.

Key takeaways

This study at Gonesse Hospital is about stroke care.
It examines how quickly patients receive clot-busting treatment after arriving.
The goal is to improve future stroke care and patient recovery.
It only reviews existing patient medical records, no new treatments.
There are no direct risks or benefits to individual patients involved.

Who may be eligible?

To be included in this study, patients need to be adults aged 18 or older. They must have had a confirmed blockage type of stroke, usually identified with a scan, and received their initial stroke care, including clot-busting treatment, at Gonesse Hospital during the study period. Crucially, the hospital must have enough clear records to work out exactly when they arrived and when their treatment started.

Patients would not be included if their stroke was caused by bleeding in the brain (rather than a clot), or if they received part of their clot-busting treatment before even reaching the hospital. Also, if there isn't enough information in their medical records to accurately calculate the treatment times, they won't be part of the study.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Did you have a stroke caused by a clot (not bleeding)?
Did you receive your initial stroke care and clot-busting treatment at Gonesse Hospital?
Are there clear records of your arrival and treatment times at the hospital?

Answer every question to see your result.

What does participation involve?

This study is looking back at existing medical records, not involving new treatments or tests for patients. If you were a patient who had a stroke at Gonesse Hospital during the study period, your medical information might be included. Taking part wouldn't involve any extra hospital visits, assessments, or medications for you. Researchers would simply look at the information already in your hospital notes. There isn't an active 'participation' in the traditional sense, as no direct patient involvement is expected or required.

Potential risks and benefits

Since this study only involves reviewing existing patient records, there are no direct risks to patients. There are also no direct benefits to individual patients because no new treatments or tests are being given. However, the potential benefit is to future stroke patients at Gonesse Hospital, as the findings from this study could help improve the speed and quality of stroke care, potentially leading to better recovery rates for others. As with all research using patient data, strict rules are followed to protect patient privacy and confidentiality. Patients cannot withdraw once their anonymised data has been used as it's retrospective.

Locations (1)

France
Verified postcode
Gonesse, France

Common questions

What is 'Door-to-Needle Time'?

It's the time from when a patient arrives at the hospital emergency room after a stroke to when they receive their first dose of clot-busting medication through an injection.

What is a 'clot-busting treatment'?

This is a medicine, given by injection, that helps dissolve blood clots that are blocking blood flow to the brain, which is a common cause of stroke.

Will I need to do anything if I'm in this study?

No, this study looks at past patient records. You wouldn't need to visit the hospital, take any new medicines, or do anything extra.

Who is paying for this study?

The information provided doesn't state who is funding the study. This is a common detail not always included in brief summaries.

Why is this study important?

It's important because faster treatment for a stroke can often lead to a better recovery. This study aims to help Gonesse Hospital find ways to make their stroke care even quicker and more effective.